Novel retinoblastoma treatment avoids chemotherapy: The effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors

Samuel K. Houston, Yolanda Piña, Timothy G. Murray, Hinda Boutrid, Colleen Cebulla, Amy C. Schefler, Wei Shi, Magda Celdran, William Feuer, Jaime Merchan, Ted J. Lampidis

Research output: Contribution to journalArticle

10 Scopus citations

Fingerprint Dive into the research topics of 'Novel retinoblastoma treatment avoids chemotherapy: The effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH<sub>BETA</sub>T<sub>AG</sub> retinoblastoma tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences